Lorediplon

CAS No. 917393-39-6

Lorediplon( GF-015535-00 )

Catalog No. M16588 CAS No. 917393-39-6

A partial positive allosteric GABAA receptor modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 Get Quote
25MG 72 Get Quote
50MG 140 Get Quote
100MG 219 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lorediplon
  • Note
    Research use only, not for human use.
  • Brief Description
    A partial positive allosteric GABAA receptor modulator.
  • Description
    A partial positive allosteric GABAA receptor modulator; displays activity at the alpha1-subunit, associated with promoting sleep.Sleep Disorder Phase 1 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GF-015535-00
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    GAT
  • Recptor
    GAT
  • Research Area
    Neurological Disease
  • Indication
    Sleep Disorder

Chemical Information

  • CAS Number
    917393-39-6
  • Formula Weight
    394.4221
  • Molecular Formula
    C20H15FN4O2S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC(N(C1=CC(C2=CC=NC3=C(C(C4=CC=CS4)=O)C=NN23)=CC=C1F)C)=O
  • Chemical Name
    Acetamide, N-[2-fluoro-5-[3-(2-thienylcarbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]-N-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zisapel N. Expert Opin Investig Drugs. 2015 Mar;24(3):401-11.
molnova catalog
related products
  • AWD 131-138

    AWD 131-138(Imepitoin) is a new low-affinity partial benzodiazepine receptor agonist with potent anticonvulsant and anxiolytic properties in rodent models.

  • Baicalin

    Baicalin, one the effective compositions of scutellaria baicalensis, possesses multiple properities such as antioxidant, anti-tumor, anti-HIV, treating cardiovascular disease and so on.

  • Nefiracetam

    Nefiracetam is a GABAergic, cholinergic, and monoaminergic neuronal system enhancer for Ro 5-4864-induced convulsions. Phase 2.